ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,433Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 680

$667K Total Retail Price of All Prescriptions

Rank: 174 out of 680

483 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 483 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 483 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 11,633 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 710 608 1 1
SIMVASTATIN 424 385 2 3
HYDROCODONE-ACETAMINOPHEN 412 313 S3 3 4
OMEPRAZOLE 381 287 4 7
LEVOTHYROXINE SODIUM 343 304 5 2
METFORMIN HCL 314 264 6 8
FUROSEMIDE 260 254 7 6
LISINOPRIL 239 197 8 5
ATENOLOL 228 190 9 19
TRAMADOL HCL 223 207 10 18
GABAPENTIN 219 204 11 15
ZOLPIDEM TARTRATE 218 149 12 17
DOXAZOSIN MESYLATE 204 185 13 73
METOPROLOL SUCCINATE 200 190 14 13
HYDROCHLOROTHIAZIDE 186 182 15 9
CITALOPRAM HBR 181 154 16 22
PRAVASTATIN SODIUM 179 156 17 10
LOVASTATIN 172 146 18 44
ALENDRONATE SODIUM 160 160 19 32
ATORVASTATIN CALCIUM 148 135 20 11
POTASSIUM CHLORIDE 144 143 21 14
NEXIUM 138 106 22 16
METOPROLOL TARTRATE 137 117 23 12
TAMSULOSIN HCL 136 100 24 34
DIOVAN 133 122 25 31
RAMIPRIL 132 108 26 69
BENAZEPRIL HCL 123 116 27 40
SERTRALINE HCL 121 91 28 28
CLONIDINE HCL 117 74 29 36
AMLODIPINE BESYLATE-BENAZEPRIL 107 107 30 43
FENOFIBRATE 104 54 31 66
WARFARIN SODIUM 103 98 32 20
SYNTHROID 99 87 33 38
PANTOPRAZOLE SODIUM 99 90 33 30
CARVEDILOL 99 99 33 23
LANTUS 97 73 36 49
FAMOTIDINE 97 89 36 89
KLOR-CON M20 97 81 36 61
CLOPIDOGREL 97 97 36 26
LACTULOSE 95 94 40 92
ALLOPURINOL 87 87 41 33
LOSARTAN POTASSIUM 83 69 42 21
ESCITALOPRAM OXALATE 83 58 42 45
GLIPIZIDE ER 80 59 44 108
ACTOS 77 76 45 114
PLAVIX 75 75 46 39
MELOXICAM 74 62 47 24
BYSTOLIC 71 67 48 79
DONEPEZIL HCL 70 68 49 27
GLIPIZIDE XL 70 48 49 142
DOXYCYCLINE HYCLATE 69 59 51 95
CYMBALTA 69 64 51 46
BUMETANIDE 68 56 53 102
NAMENDA 67 67 54 35
MECLIZINE HCL 64 42 55 103
ADVAIR DISKUS 64 62 55 53
TRIAMTERENE-HCTZ 62 62 57 52
CELEBREX 62 58 57 90
QUINAPRIL HCL 62 51 57 104
ESTRADIOL 59 59 R 60 134
NIFEDIPINE ER 57 44 61 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 57 42 61 37
PROMETHAZINE HCL 55 45 R 63 96
NIFEDIAC CC 55 55 63 281
CRESTOR 55 53 63 25
GLIMEPIRIDE 54 54 66 29
CYCLOBENZAPRINE HCL 52 28 R 67 81
LANTUS SOLOSTAR 52 45 67 84
JANUVIA 51 47 69 60
KLOR-CON M10 51 51 69 127
MIRTAZAPINE 50 50 71 78
EVISTA 50 50 71 135
CARAFATE 50 47 71 273
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.